Nephrotoxicity of calcineurin inhibitors: new therapeutic approaches (Q33844441)

29 July 2017

1 reference

title

Nephrotoxicity of calcineurin inhibitors: new therapeutic approaches (English)

1 reference

29 July 2017

D Abramowicz

1

1 reference

29 July 2017

K M Wissing

series ordinal

2

1 reference

29 July 2017

N Broeders

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

Transplantation Proceedings

29 July 2017

1 reference

29 July 2017

32

1 reference

29 July 2017

1A Suppl

1 reference

29 July 2017

3S-5S

1 reference

Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2900807-1

7 January 2021

Chronic rejection and chronic cyclosporin toxicity in renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2900807-1

7 January 2021

Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2900807-1

7 January 2021

Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2900807-1

7 January 2021

Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2900807-1

7 January 2021

Can antibody prophylaxis allow sparing of other immunosuppressives?

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2900807-1

7 January 2021

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2900807-1

7 January 2021

A novel approach to the treatment of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2900807-1

7 January 2021

LOW-DOSE CYCLOSPORINE AND MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS WITH SUBOPTIMAL RENAL FUNCTION1,2

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2900807-1

7 January 2021

Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2900807-1

7 January 2021

Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2900807-1

7 January 2021

Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2900807-1

7 January 2021

10.1016/S0041-1345(00)00807-1

Identifiers

DOI

1 reference

29 July 2017

1 reference